Ngā hua rapu - Kalamarides, Michel
- E whakaatu ana i te 1 - 20 hua o te 37
- Haere ki te Whārangi Whai Ake
-
1
TERT, the target? mā Sahm, Felix, Kalamarides, Michel
I whakaputaina 2018Text -
2
-
3
-
4
-
5
-
6
Miniaturized Handheld Confocal Microscopy Identifies Focal Brain Invasion in a Mouse Model of Aggressive Meningioma mā Peyre, Matthieu, Clermont‐Taranchon, Estelle, Stemmer‐Rachamimov, Anat, Kalamarides, Michel
I whakaputaina 2013Text -
7
-
8
Clinical and Histologic Parameters Correlated with Facial Nerve Function After Vestibular Schwannoma Surgery mā Couloigner, Vincent, Gervaz, Elena, Kalamarides, Michel, Ferrary, Evelyne, Rey, Alain, Sterkers, Olivier, Hénin, Dominique
I whakaputaina 2003Text -
9
High Incidence of Activating TERT Promoter Mutations in Meningiomas Undergoing Malignant Progression mā Goutagny, Stéphane, Nault, Jean C., Mallet, Maxime, Henin, Dominique, Rossi, Jessica Z., Kalamarides, Michel
I whakaputaina 2013Text -
10
Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2 mā Peyre, Matthieu, Goutagny, Stephane, Imbeaud, Sandrine, Bozorg-Grayeli, Alexis, Felce, Michele, Sterkers, Olivier, Kalamarides, Michel
I whakaputaina 2011Text -
11
Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features mā Goutagny, Stéphane, Bah, Alpha Boubacar, Henin, Dominique, Parfait, Béatrice, Grayeli, Alexis Bozorg, Sterkers, Olivier, Kalamarides, Michel
I whakaputaina 2012Text -
12
Broad-Range 16S rRNA PCR with Cerebrospinal Fluid May Be Unreliable for Management of Postoperative Aseptic Meningitis mā Zarrouk, Virginie, Leflon-Guibout, Véronique, Robineaux, Sébastien, Kalamarides, Michel, Nicolas-Chanoine, Marie-Hélène, Sterkers, Olivier, Fantin, Bruno
I whakaputaina 2010Text -
13
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse mā Kalamarides, Michel, Niwa-Kawakita, Michiko, Leblois, Hélène, Abramowski, Vincent, Perricaudet, Michel, Janin, Anne, Thomas, Gilles, Gutmann, David H., Giovannini, Marco
I whakaputaina 2002Text -
14
Natural History of Meningioma Development in Mice Reveals: A Synergy of Nf2 and p16 (Ink4a) Mutations mā Kalamarides, Michel, Stemmer‐Rachamimov, Anat O., Takahashi, Masaya, Han, Zhi‐Yan, Chareyre, Fabrice, Niwa‐Kawakita, Michiko, Black, Peter M., Carroll, Rona S., Giovannini, Marco
I whakaputaina 2007Text -
15
Alternative Splicing of CHEK2 and Codeletion with NF2 Promote Chromosomal Instability in Meningioma mā Yang, Hong Wei, Kim, Tae-Min, Song, Sydney S, Shrinath, Nihal, Park, Richard, Kalamarides, Michel, Park, Peter J, Black, Peter M, Carroll, Rona S, Johnson, Mark D
I whakaputaina 2012Text -
16
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma mā Giovannini, Marco, Bonne, Nicolas-Xavier, Vitte, Jeremie, Chareyre, Fabrice, Tanaka, Karo, Adams, Rocky, Fisher, Laurel M., Valeyrie-Allanore, Laurence, Wolkenstein, Pierre, Goutagny, Stephane, Kalamarides, Michel
I whakaputaina 2014Text -
17
De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors mā Peyre, Matthieu, Gauchotte, Guillaume, Giry, Marine, Froehlich, Sébastien, Pallud, Johan, Graillon, Thomas, Bielle, Franck, Cazals-Hatem, Dominique, Varlet, Pascale, Figarella-Branger, Dominique, Loiseau, Hugues, Kalamarides, Michel
I whakaputaina 2018Text -
18
Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas mā Boin, Alizée, Couvelard, Anne, Couderc, Christophe, Brito, Isabel, Filipescu, Dan, Kalamarides, Michel, Bedossa, Pierre, De Koning, Leanne, Danelsky, Carine, Dubois, Thierry, Hupé, Philippe, Louvard,, Daniel, Lallemand, Dominique
I whakaputaina 2014Text -
19
Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis mā Louvrier, Camille, Pasmant, Eric, Briand-Suleau, Audrey, Cohen, Joëlle, Nitschké, Patrick, Nectoux, Juliette, Orhant, Lucie, Zordan, Cécile, Goizet, Cyril, Goutagny, Stéphane, Lallemand, Dominique, Vidaud, Michel, Vidaud, Dominique, Kalamarides, Michel, Parfait, Béatrice
I whakaputaina 2018Text -
20
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study mā Graillon, Thomas, Ferrer, Loic, Siffre, Jason, Sanson, Marc, Peyre, Matthieu, Peyrière, Hadrien, Mougel, Grégory, Autran, Didier, Tabouret, Emeline, Figarella-Branger, Dominique, Barlier, Anne, Kalamarides, Michel, Dufour, Henry, Colin, Thierry, Chinot, Olivier
I whakaputaina 2021Text